Konen, F.F.; Hannich, M.J.; Schwenkenbecher, P.; Grothe, M.; Gag, K.; Jendretzky, K.F.; Gingele, S.; Sühs, K.-W.; Witte, T.; Skripuletz, T.;
et al. Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple Sclerosis. Biomedicines 2022, 10, 1629.
https://doi.org/10.3390/biomedicines10071629
AMA Style
Konen FF, Hannich MJ, Schwenkenbecher P, Grothe M, Gag K, Jendretzky KF, Gingele S, Sühs K-W, Witte T, Skripuletz T,
et al. Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple Sclerosis. Biomedicines. 2022; 10(7):1629.
https://doi.org/10.3390/biomedicines10071629
Chicago/Turabian Style
Konen, Franz Felix, Malte Johannes Hannich, Philipp Schwenkenbecher, Matthias Grothe, Konrad Gag, Konstantin Fritz Jendretzky, Stefan Gingele, Kurt-Wolfram Sühs, Torsten Witte, Thomas Skripuletz,
and et al. 2022. "Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple Sclerosis" Biomedicines 10, no. 7: 1629.
https://doi.org/10.3390/biomedicines10071629
APA Style
Konen, F. F., Hannich, M. J., Schwenkenbecher, P., Grothe, M., Gag, K., Jendretzky, K. F., Gingele, S., Sühs, K. -W., Witte, T., Skripuletz, T., & Süße, M.
(2022). Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple Sclerosis. Biomedicines, 10(7), 1629.
https://doi.org/10.3390/biomedicines10071629